HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N3-(2-carbamoyl-2-hydroxyethyl)adenine

structure in first source

Also Known As:

N3-GA-Ade

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Adenine: 2120
        N3-(2-carbamoyl-2-hydroxyethyl)adenine: 1

Experts

1.	Beland, Frederick A: 1 article (02/2007)
2.	Churchwell, Mona I: 1 article (02/2007)
3.	Doerge, Daniel R: 1 article (02/2007)
4.	Gamboa da Costa, Gonçalo: 1 article (02/2007)
5.	Gaspar, Jorge Francisco: 1 article (02/2007)
6.	Marques, M Matilde: 1 article (02/2007)
7.	Martins, Célia: 1 article (02/2007)
8.	Martins, Vanda: 1 article (02/2007)
9.	Oliveira, Nuno G: 1 article (02/2007)
10.	Pingarilho, Marta: 1 article (02/2007)

Related Diseases

1.

Chromosome Aberrations (Chromosome Abnormalities)

02/01/2007 - "For this purpose, we evaluated two cytogenetic end points, chromosomal aberrations (CAs) and sister chromatid exchanges (SCEs), as well as the levels of specific GA-DNA adducts, namely, N7-(2-carbamoyl-2-hydroxyethyl)guanine (N7-GA-Gua) and N3-(2-carbamoyl-2-hydroxyethyl)adenine (N3-GA-Ade) using high-performance liquid chromatography coupled with tandem mass spectrometry. "

Related Drugs and Biologics

1.	DNA Adducts
2.	N7-(2-carbamoyl-2-hydroxyethyl)guanine